Skip to content
Review Open access

Dietary Bioactive Compounds: Cellular Sensory Pathways, Microbial Partners, and Clinical Realities

Sep 2026 · Nutrients · Vol 18, pp. 3001 · 0 citations · 255 references
Medicine

TL;DR

Dietary BCs show therapeutic potential as modulators of molecular and microbial pathways relevant to chronic diseases, however, findings remain limited by heterogeneity in study design, intervention duration, and compound characterization.

Abstract

Background/Objectives: Dietary bioactive compounds (BCs) modulate multiple cellular pathways involved in inflammation, oxidative stress, energy metabolism, and tissue homeostasis. This narrative review aimed to synthesize the mechanistic roles and therapeutic relevance of major dietary BC classes, including polyphenols, carotenoids, organosulfur compounds, and polyunsaturated fatty acids, in chronic non-communicable diseases. Methods: We conducted a narrative review to integrate current evidence on the classification, bioavailability, molecular targets, microbiota interactions, and clinical relevance of dietary BCs. The literature considered experimental, observational, and clinical studies addressing key signaling pathways, including NF-κB, Nrf2, AMPK, mTOR, SIRT1, PPARs, and the NLRP3 inflammasome, as well as the diet–microbiota–host axis. Results: The literature indicates that BCs exert pleiotropic effects through the coordinated modulation of transcription factors, metabolic sensors, nuclear receptors, and inflammatory mediators. Their biological activity is also shaped by bioavailability, food matrix effects, host metabolism, and gut microbial transformation into bioactive metabolites. Across obesity, type 2 diabetes, cardiovascular disease, inflammatory bowel disease, and neurodegenerative conditions, BCs appear associated with improved inflammatory, metabolic, and redox regulation. However, findings remain limited by heterogeneity in study design, intervention duration, and compound characterization. Conclusions: Dietary BCs show therapeutic potential as modulators of molecular and microbial pathways relevant to chronic diseases. However, greater standardization in study design and longer-term human trials are needed to support robust evidence-based recommendations.

Read PDF

Similar papers

Review Open access Sep 2026

Plant-food components at the microbiota–neuroinflammation interface: human evidence, translational limits, and sustainable dietary translation

This narrative review evaluates how convincingly plant-food components and plant-rich dietary patterns influence neuroinflammation and whether those mechanisms translate into neurological benefit. Infection is treated as one possible initiating exposure, neuroinflammation as a context-dependent mechanism, and neurologi...

K. E. Dunga, Sylvester Chibueze Izah, A. Dunkwu-Okafor et al. · 0 citations
Review Open access Oct 2026

Dietary Polyphenols and Cardiovascular Health: From Bioavailability to Clinical Relevance

Dietary polyphenols, abundant in fruits, vegetables, tea, coffee, cocoa, and wine, have been widely investigated for their potential relevance to cardiovascular health. Their proposed protective effects extend beyond classical antioxidant activity, encompassing regulation of redox-sensitive signaling, attenuation of in...

Maja Krstić Ristivojević, Dušan Ružičić, M. Trif et al. · 0 citations
Review Open access Sep 2026

Marine Fish-Derived Bioactive Compounds: Nutritional Pathways Toward Human Health Benefits

Marine fish-derived bioactive compounds have emerged as pivotal agents in bridging nutrition and therapeutic innovation, offering multifaceted health benefits through anti-inflammatory, antioxidant, and metabolic regulatory mechanisms. This review synthesises current evidence on omega-3 fatty acids (EPA/DHA), bioactive...

M. R. Washikur, Mohammad Nazir Hossain · 0 citations
Review Open access Sep 2026

Short‐Chain Fatty Acids: Microbial Metabolites Driving Gut‐Eye Axis Signaling

ABSTRACT Short‐chain fatty acids (SCFAs) have emerged as key molecular mediators of gut–eye communication, linking microbial metabolism to ocular physiology and disease. Produced through microbial fermentation of dietary fiber, SCFAs function as systemic signaling molecules that regulate immune homeostasis, metabolic f...

Aleah J. Brokemond, Ronny Amamoo, Fapianey J. Alexandre et al. · 0 citations
Review Sep 2026

Next-Generation Nutraceuticals Targeting the Gut–Brain Axis: Mechanisms and Clinical Evidence

The gut–brain axis has emerged as a key regulator of neurological and mental health, yet nutraceutical research in this field remains dominated by probiotics, while a broader range of diet-derived bioactive compounds that modulate gut–brain communication without live microbes receives far less attention. This integrati...

M. Khalid · 0 citations
Conference Open access 2026

The Protective Role of Gut Microbiota Metabolites in Cardiovascular Disease

Gut microbial metabolites provide critical cardioprotection across all CVD pathological stages via immune regulation, metabolic balance, endothelial protection, and anti-fibrosis effects.

Jing-Yi Chen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.